Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Assembly Biosciences (ASMB) Return on Capital Employed (2016 - 2025)

Assembly Biosciences (ASMB) has 11 years of Return on Capital Employed data on record, last reported at 0.41% in Q3 2025.

  • For Q3 2025, Return on Capital Employed rose 30.0% year-over-year to 0.41%; the TTM value through Sep 2025 reached 0.41%, up 30.0%, while the annual FY2024 figure was 0.57%, 24.0% up from the prior year.
  • Return on Capital Employed reached 0.41% in Q3 2025 per ASMB's latest filing, up from 1.02% in the prior quarter.
  • Across five years, Return on Capital Employed topped out at 0.24% in Q1 2021 and bottomed at 1.44% in Q3 2023.
  • Average Return on Capital Employed over 5 years is 0.81%, with a median of 0.73% recorded in 2024.
  • Peak YoY movement for Return on Capital Employed: tumbled -69bps in 2022, then surged 74bps in 2024.
  • A 5-year view of Return on Capital Employed shows it stood at 0.65% in 2021, then crashed by -52bps to 0.99% in 2022, then decreased by -19bps to 1.18% in 2023, then skyrocketed by 38bps to 0.73% in 2024, then skyrocketed by 45bps to 0.41% in 2025.
  • Per Business Quant database, its latest 3 readings for Return on Capital Employed were 0.41% in Q3 2025, 1.02% in Q2 2025, and 0.71% in Q1 2025.